8 completed, 1 terminated. 4 Phase 1, 2 Phase 2, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Gonorrhoea: new trials by email Literature Review of Gonorrhoea trials Research Report on Gonorrhoea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination Meningococcal Group B Vaccine, Placebo - Gonorrhoea | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 52 | 2021-11-01 | 2026-10-21 |
| Clinical Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) Utilizing Vaginal Swabs Click Device - Chlamydial Infection, Gonorrhoea | Not applicable | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 295 | 2018-07-09 | 2021-08-24 |
| A Study to Evaluate the Safety, Tolerability and Plasma PK of a Single Oral Dose of Zoliflodacin in Healthy Male and Female Volunteers AZD0914 - Gonorrhoea | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 8 | 2018-02-02 | 2019-03-18 |
| Cefixime / Azithromycin pK Study Azithromycin, Cefixime - Gonorrhoea | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 10 | 2016-04-28 | 2017-09-15 |
| Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin Solithromycin - Gonorrhoea | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 28 | 2015-05-05 | 2019-01-28 |
| Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea Gonorrhoea | Completed | University of Bern | 261 | 2015-02-01 | 2019-07-16 | |
| Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea AZD0914, Ceftriaxone - Gonorrhoea | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 180 | 2014-11-25 | 2017-03-22 |
| The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study Cefixime - Gonorrhoea | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 25 | 2013-12-01 | 2019-01-17 |
| Efficacy of Combination Therapies for Gonorrhea Treatment Azithromycin, Gentamicin, Gemifloxacin - Gonorrhoea | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 614 | 2010-06-01 | 2015-08-19 |
Gonorrhea (9) · Chlamydia Infections (1) · Disease (1) · Disease Susceptibility (1) · Sexually Transmitted Diseases (1) · Trichomonas Infections (1)
Bacterial Infections (9) · Bacterial Infections and Mycoses (9) · Communicable Diseases (9) · Genital Diseases (9) · Gram-Negative Bacterial Infections (9) · Infections (9) · Neisseriaceae Infections (9) · Sexually Transmitted Diseases, Bacterial (9) · Urogenital Diseases (9) · Sexually Transmitted Diseases (8) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Disease Attributes (2) · Chlamydiaceae Infections (1) · Parasitic Diseases (1)
Azithromycin (2) · Cefixime (2) · zoliflodacin (2) · 4CMenB vaccine (1) · Ceftriaxone (1) · Gemifloxacin (1) · Gentamicins (1) · solithromycin (1)
National Institute of Allergy and Infectious Diseases (NIAID) (8) · University of Bern (1)
United States (8) · Switzerland (1)
Nicola Low (1)
PMID 25031289, PMID 29624558, PMID 29950339, PMID 30403954
5UM1AI148576-05 (1)